BOONE CAPITAL MANAGEMENT LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001882053
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 13 positions · Total reported value $296.47M · Top-10 concentration 89.7% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 71.4% · 5 new · 5 cut · 5 exited
Active Share (vs S&P 500): 99.4% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -7.2% · vs SPY -9.3% · Prev Value $427.54M — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +6.8% · vs SPY +4.6% · Latest Value $376.70M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2024 13F filing, BOONE CAPITAL MANAGEMENT LLC disclosed 13 equity positions with a combined reported value of $296.47M. The filing implies a focused portfolio: its ten largest positions account for 89.7% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2024 were UNM ($58.71M), GMED ($47.02M), PRGO ($26.29M). By sector, the heaviest allocations are Health Care 76.6%, Financials 23.4%. Versus the prior quarter, allocation shifted toward Financials (+8.6pp), Health Care (+1.8pp) and away from Technology (-1.6pp), Other (-4.3pp).
Versus the prior quarter, BOONE CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 5 and fully exited 5, a turnover rate of 71.4% of positions. The portfolio's overlap with the prior quarter was 58% of names.
The largest new positions opened in Q4 2024 were BHVN ($13.50M), GNW ($10.74M).
Of the 5 positions fully exited versus the prior quarter, the largest were CHE ($23.69M), DHR ($17.05M), BAX ($16.78M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
- BHVN BIOHAVEN LTD · $13.50M
- GNW GENWORTH FINL INC · $10.74M
Insider Transactions (Form 4)
Latest BOONE CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Boone Capital Management is an SEC-registered 13F filer based in Atlanta, GA, United States. As of Q3 2026 it reported 16 US equity positions with a combined value of $376.70M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: ATLANTA, GA, United States
- SEC registration: 801-126199 (status: Approved), registered 2022-07-27
- Regulatory AUM (Form ADV): $963.17M as of 2026-03-30
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 16 positions · $376.70M reported value (Q3 2026)
- Top 10 holdings = 81.1% of reported value
- Largest position: BMRN (BIOMARIN PHARMACEUTICAL INC) at 10.7%
- Average position size: $23.54M
Sector Tilt
- Health Care 75.8%
- Consumer Staples 7.8%
- Industrials 7.3%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 5 new, 3 added, 5 reduced, 5 exited
- 3 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
803.87K | $58.71M | 19.80% | Reduce | |
| 2 |
|
568.47K | $47.02M | 15.86% | Reduce | |
| 3 |
|
1.02M | $26.29M | 8.87% | Add | |
| 4 |
|
581.84K | $24.06M | 8.12% | Add | |
| 5 |
|
81.84K | $23.82M | 8.04% | Add | |
| 6 |
|
85.86K | $23.71M | 8.00% | Reduce | |
| 7 |
|
1.06M | $18.46M | 6.23% | Add | |
| 8 |
|
641.25K | $17.01M | 5.74% | Hold | |
| 9 |
|
361.42K | $13.50M | 4.55% | New | |
| 10 |
|
524.87K | $13.49M | 4.55% | Reduce | |
| 11 |
|
57.14K | $11.23M | 3.79% | Reduce | |
| 12 |
|
1.54M | $10.74M | 3.62% | New | |
| 13 |
|
209.85K | $8.44M | 2.85% | Add | |
FAQ
What did BOONE CAPITAL MANAGEMENT LLC buy in 2024-Q4?
In its 2024-Q4 13F filing, BOONE CAPITAL MANAGEMENT LLC reported 13 equity positions worth $296.47M in aggregate; its largest disclosed positions were UNM ($58.71M), GMED ($47.02M), PRGO ($26.29M).
How large is BOONE CAPITAL MANAGEMENT LLC's portfolio?
BOONE CAPITAL MANAGEMENT LLC reported $296.47M of long equity holdings across 13 positions as of 2024-Q4. Top-10 holdings account for 89.7% of reported value.
What is BOONE CAPITAL MANAGEMENT LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.